MEDIA COVERAGE OF THE PERSISTENT VEGETATIVE STATE AND END-OF-LIFE DECISION-MAKING
THERESA SCHIAVO'S TRAGEDY AND OURS, TOO
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Racine et al.1 described some aspects of Terri Schiavo’s life and death. Dr. Bernat’s2 accompanying editorial comments on the media aspects of this case.
In 1991, I was part of a team at the University of California, San Francisco, that evaluated the brain and cognitive functions of Terri Schiavo and other patients in persistent vegetative states (PVS). These evaluations were carried out as part of an experimental treatment protocol conducted by Hosobuchi and Yingling.3
After presurgical evaluations were complete, Dr. Hosobuchi implanted 2 patients with stimulating electrodes in the high cervical spinal cord, and he implanted 4 patients with electrodes in the centrum medianum of the thalamus. Unfortunately, most of the patients in the study did not exhibit improvement because the extent of their brain damage was too severe to allow recovery of normal functions. Because Terri Schiavo was a member of the nonresponsive group, I agree with Michael Schiavo’s decision to end his wife’s life in 2005. Fifteen years seems long enough—too long, some might argue—to remain in such a state with no chance for improvement.
I was motivated to write this correspondence by stories I have heard about several different individuals who unexpectedly entered a comatose state. In each of these cases, within 1 week of the onset of coma, physicians told family members …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.